VYGR

Voyager Therapeutics (VYGR)

About Voyager Therapeutics (VYGR)

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.

Details

Daily high

$4.33

Daily low

$4.11

Price at open

$4.28

52 Week High

$6.27

52 Week Low

$2.64

Market cap

236.9M

Dividend yield

0.00%

Volume

350,094

Avg. volume

471,537

P/E ratio

-1.96

Voyager Therapeutics News